7713.TWO WeLeader Biomedical Co., Ltd.

Healthcare Medical Devices Taiwan OTC Exchange
70.50 TWD
Close of Nov 6, 2026
63.17 76.58
Market cap
TWD 3.21B
P/E
14.0x
P/B
2.67x
ROE
21.9%
Dividend yield
4.78%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 7713.TWO undervalued?

Graham number
Price70.50
Graham value54.77
Premium28.7%

7713.TWO trades 28.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

WeLeader Biomedical Co., Ltd. fundamental analysis

No fundamental analysis for WeLeader Biomedical Co., Ltd. yet.

WeLeader Biomedical Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About WeLeader Biomedical Co., Ltd.

WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system. The company also provides blood gas electrolyte analyzers, urine analyzers, integrated fully automatic biochemical analyzers, fully automatic electronic luminescence immunoassay products, fully automatic modular biochemical i…

Full company profile